NEW YORK STATE COMMON RETIREMENT FUND - IMPEL NEUROPHARMA INC ownership

Back to all holdings Add to watchlist

IMPEL NEUROPHARMA INC's ticker is IMPL and the CUSIP is 45258K109. A total of 34 filers reported holding IMPEL NEUROPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.

Links
Filings
External links
Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of IMPEL NEUROPHARMA INC
ValueSharesWeighting
Q2 2022$0
-100.0%
45
-99.3%
0.00%–
Q1 2022$44,000
-25.4%
6,847
-0.3%
0.00%–
Q4 2021$59,000
-29.8%
6,8670.0%0.00%–
Q3 2021$84,000
-30.6%
6,867
-49.9%
0.00%–
Q2 2021$121,000–13,700–0.00%–
 Download
Other shareholders
IMPEL NEUROPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
NVP Associates, LLC 3,077,198$1,323,1951.18%
5AM Venture Management, LLC 2,884,791$1,240,4600.36%
venBio Partners LLC 2,759,791$1,186,7100.34%
Vivo Capital, LLC 2,884,789$1,240,4590.14%
LASRY MARC 225,874$97,1260.10%
Kohlberg Kravis Roberts & Co. L.P. 4,135,971$1,778,4680.06%
DCF Advisers, LLC 178,500$76,7550.04%
EPIQ PARTNERS, LLC 16,325$7,0200.01%
MCDONALD PARTNERS LLC 19,400$8,3420.00%
XTX Topco Ltd 21,222$9,1250.00%
View complete list of IMPEL NEUROPHARMA INC shareholders